[go: up one dir, main page]

BR9909324A - Acidic composition for topical treatment of skin and nail conditions - Google Patents

Acidic composition for topical treatment of skin and nail conditions

Info

Publication number
BR9909324A
BR9909324A BR9909324-3A BR9909324A BR9909324A BR 9909324 A BR9909324 A BR 9909324A BR 9909324 A BR9909324 A BR 9909324A BR 9909324 A BR9909324 A BR 9909324A
Authority
BR
Brazil
Prior art keywords
skin
topical treatment
relates
composition
nails
Prior art date
Application number
BR9909324-3A
Other languages
Portuguese (pt)
Inventor
Ying Sun
Jue-Chen Liu
Elizabeth Kimbleton
Jonas C T Wang
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of BR9909324A publication Critical patent/BR9909324A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçãO ACIDIFICADA PARA TRATAMENTO TóPICO DE CONDIçõES DA PELE E UNHA"<D>. A presente invenção refere-se a um método para o tratamento tópico de doenças da pele e unhas humanas, incluindo infecções fúngicas, infecções bacterianas e infecções psoriáticas. Além disso, a presente invenção se refere a um método de tratamento das condições gerais das unhas humanas, incluindo sua resistência, taxa de desenvolvimento e aparência. Mais particularmente, a invenção se refere a uma composição acidificada e métodos de uso da referida composição. Ainda, a invenção se refere a uma laca acidificada útil no tratamento de pele e unhas humanas.Invention Patent: <B> "ACIDIFIED COMPOSITION FOR TOPICAL TREATMENT OF SKIN AND NAIL CONDITIONS" <D>. The present invention relates to a method for the topical treatment of diseases of the human skin and nails, including fungal infections, bacterial infections and psoriatic infections. In addition, the present invention relates to a method of treating the general conditions of human nails, including their strength, rate of development and appearance. More particularly, the invention relates to an acidified composition and methods of using said composition. In addition, the invention relates to an acidified lacquer useful in the treatment of human skin and nails.

BR9909324-3A 1998-03-31 1999-03-29 Acidic composition for topical treatment of skin and nail conditions BR9909324A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8011698P 1998-03-31 1998-03-31
PCT/US1999/006740 WO1999049835A1 (en) 1998-03-31 1999-03-29 An acidified composition for topical treatment of nail and skin conditions

Publications (1)

Publication Number Publication Date
BR9909324A true BR9909324A (en) 2000-12-05

Family

ID=22155365

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909324-3A BR9909324A (en) 1998-03-31 1999-03-29 Acidic composition for topical treatment of skin and nail conditions

Country Status (11)

Country Link
US (1) US6231875B1 (en)
EP (1) EP1067897A1 (en)
JP (1) JP2002509867A (en)
KR (1) KR20010042324A (en)
CN (1) CN1198563C (en)
AR (1) AR015257A1 (en)
AU (1) AU3211999A (en)
BR (1) BR9909324A (en)
CA (1) CA2326774A1 (en)
TW (1) TWI225407B (en)
WO (1) WO1999049835A1 (en)

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US20040039030A1 (en) 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE19639816A1 (en) 1996-09-27 1998-04-02 Hoechst Ag Antifungal agents with high drug release
DE19639817A1 (en) 1996-09-27 1998-04-02 Hoechst Ag Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AUPO983897A0 (en) * 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
US20030235607A1 (en) * 1998-02-13 2003-12-25 Buck Carol J. Compositions and methods for inhibiting fungal growth and transference
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
HRP20010576A2 (en) * 1999-02-03 2002-08-31 Biogal Gyogyszergyar Process for the preparation of pseudomonic acid a antibiotic by microbiological method
DE19921794A1 (en) * 1999-05-11 2000-11-23 Hexal Ag New pharmaceutical composition
CA2291346A1 (en) * 1999-11-26 2001-05-26 Bernard Charles Sherman Antifungal solutions
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
AU4318901A (en) * 2000-02-16 2001-08-27 Bentley Pharmaceuticals Inc Pharmaceutical composition
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
DE10011081A1 (en) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Anti-infective drug combinations and their use for the topical treatment of fungal diseases of the toenails and fingernails
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
JP4814414B2 (en) * 2000-05-26 2011-11-16 大正製薬株式会社 Antifungal liquid composition
DE10035991A1 (en) * 2000-07-24 2002-02-14 Polichem Sa Nail polish composition
JP4899139B2 (en) * 2000-08-10 2012-03-21 株式会社ポーラファルマ Antifungal pharmaceutical composition
JP3838856B2 (en) * 2000-09-11 2006-10-25 日本パーカライジング株式会社 Organic hydrophilic treatment agent for aluminum-containing metal material and treatment method thereof
US20040014848A1 (en) * 2000-09-11 2004-01-22 Kazuya Tanaka Organic Hydrophicizing agent for aluminiferous metals
DE10047486A1 (en) * 2000-09-26 2002-04-11 Bayer Ag Phenoxyphenyl alkanesulfonates
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
KR100435141B1 (en) * 2000-12-28 2004-06-09 한미약품 주식회사 Composition for oral administration of poorly soluble antifungal agent and process for the preparation thereof
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US6878365B2 (en) * 2001-03-10 2005-04-12 James Edward Brehove Topical application for treating toenail fungus
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
ES2228294T1 (en) * 2001-06-21 2005-04-16 Biogal Gyogyszergyar Rt. CONTROLLED METABOLIC FERMENTATION PROCESS FOR THE PRODUCTION OF PSEUDOMONIC ACID.
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
KR100455216B1 (en) * 2001-06-27 2004-11-09 한미약품 주식회사 Composition for oral administration of poorly soluble antifungal agent and process for the preparation thereof
FR2830449B1 (en) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique USE OF TAZAROTENE FOR THE PREPARATION OF A NAIL VARNISH FOR THE TREATMENT AND / OR PREVENTION OF PSORIASIS AND A NAIL VARNISH CONTAINING IT
WO2003047503A2 (en) * 2001-10-22 2003-06-12 University Of Mississippi Delivery of medicaments to the nail
US20040072810A1 (en) 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
AU2002356953A1 (en) * 2001-11-16 2004-06-03 Beatrice M. Klysz Anti-aging skin care composition and uses thereof
AU2002364898A1 (en) * 2001-11-30 2003-06-10 Almell, Ltd. Coating for nail care having antimicrobial properties
AU2002365431A1 (en) * 2001-12-28 2003-09-02 Teva Gyogyszergyar Reszvenytarsasag Processes for preparing crystalline and amorphous mupirocin calcium
US7198794B1 (en) 2002-02-22 2007-04-03 Lorri Riley Topical formulation for treating fingernails and toenails
CA2383296A1 (en) * 2002-05-10 2003-11-10 Ginette Godbout Formulation for improving nail health and structure; method of use
JPWO2003105903A1 (en) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 Antifungal pharmaceutical composition
US7491768B2 (en) * 2002-06-25 2009-02-17 Woong-Sig Moon Polymer resin formulation having anti-microbial or anti-coagulability and preparation method thereof
JP4081312B2 (en) * 2002-06-28 2008-04-23 佐藤製薬株式会社 Antifungal agent for external use
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
GB2392446A (en) * 2002-09-02 2004-03-03 Reckitt Benckiser Nv Resin comprising water-soluble polymer and water-soluble filler
AU2003270273B2 (en) * 2002-09-05 2009-03-19 Galderma S.A. Solution for ungual application
US7374772B2 (en) * 2002-11-07 2008-05-20 Bommarito Alexander A Topical antifungal treatment
WO2004046097A1 (en) * 2002-11-18 2004-06-03 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
AU2004206769B2 (en) 2003-01-24 2009-11-26 Stiefel Research Australia Pty Ltd Clindamycin phosphate foam
TW200501959A (en) * 2003-02-20 2005-01-16 Taisho Pharmaceutical Co Ltd Antifungal agents
US20040191194A1 (en) * 2003-03-28 2004-09-30 Carol Collins Nail composition
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
EP1637132B1 (en) * 2003-06-25 2010-10-06 Hisamitsu Pharmaceutical Co., Inc. External preparation for athlete´s foot treatment
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2006528185A (en) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション Antibiotic preparations, their use and preparation
JP2007502296A (en) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In Antibiotic product, use and formulation thereof
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2440172C (en) * 2003-09-05 2011-01-11 Bernard Charles Sherman Itraconazole solution
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2005104924A (en) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd External pharmaceutical composition
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
ATE474591T1 (en) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INSULIN TREATMENT
ITMI20040312A1 (en) * 2004-02-24 2004-05-24 Euroderm R D C S P A COMPOSITIONS FOR THE TREATMENT OF NAIL AND SKIN PATHOLOGIES
ATE499416T1 (en) * 2004-05-12 2011-03-15 Akzo Nobel Coatings Int Bv ANTIMICROBIAL ACID-CATALYZED COATING COMPOSITIONS
DE602005019509D1 (en) * 2004-06-01 2010-04-08 Teva Gyogyszergyar Zartkoeruen PROCESS FOR THE PREPARATION OF THE AMORPHIC FORM OF A MEDICAMENT
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
JP2008505124A (en) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション Pulse delivery tablets
CA2570245A1 (en) * 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections
US7842749B2 (en) * 2004-08-02 2010-11-30 Poly-Med, Inc. Tissue protecting spray-on copolymeric film composition
US20060068044A1 (en) * 2004-09-30 2006-03-30 Max Reynolds Antimicrobial compositions and applications therefore
US20100092398A1 (en) * 2004-09-30 2010-04-15 Max Reynolds Antimicrobial compositions and applications therefore
US20060078599A1 (en) * 2004-10-12 2006-04-13 Mathew Ebmeier Pharmaceutical composition applicable to body tissue
FR2884419B1 (en) * 2005-04-19 2007-06-22 Galderma Sa A FILMOGENOUS SOLUTION COMPOSITION COMPRISING VITAMIN D OR ONE OF ITS DERIVATIVES AND A CORTICOSTEROID, AND ITS USE IN DERMATOLOGY
EP1874320A1 (en) * 2005-04-19 2008-01-09 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
US9173835B2 (en) 2005-05-10 2015-11-03 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
US7793666B2 (en) * 2005-07-28 2010-09-14 Innovation Biomedical Devices, Inc. Apparatus and method for treatment of infected nail
JP5010125B2 (en) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター Film preparation for athlete's foot treatment
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
FR2892023B1 (en) * 2005-10-14 2009-09-25 Galderma Sa PHARMACEUTICAL COMPOSITION BASED ON AMOROLFIN AND WATER-SOLUBLE FILMOGENIC AGENT FOR UNIGEAL AND PERI-UNGUEAL APPLICATION
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
CN101378729B (en) * 2005-12-14 2013-09-11 扎尔斯制药公司 Compositions and methods for treating dermatological conditions
AU2006332425A1 (en) * 2006-01-02 2007-07-12 Tlt Medical Ltd. Pharmaceutical composition for the treatment of nail diseases
BRPI0709674A2 (en) 2006-03-31 2011-12-06 Stiefel Res Australia Pty Ltd sparkling suspension gel
WO2007113830A2 (en) * 2006-04-04 2007-10-11 Avner Shemer Kit for treating skin infection
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20080064669A1 (en) * 2006-08-29 2008-03-13 Rakefet Cohen Stable pharmacologically active compositions including vitamin D-containing and corticosteroid compounds with low pH compatibility
US8727855B2 (en) * 2006-11-13 2014-05-20 Igt Three-dimensional paylines for gaming machines
US20080153122A1 (en) * 2006-12-21 2008-06-26 Susan Beth Cantor Method and system for enhancing self-treatment of onychomycosis
TWI433674B (en) 2006-12-28 2014-04-11 Infinity Discovery Inc Cyclopamine analogs
EP1958613A1 (en) * 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
WO2009084020A2 (en) * 2007-10-18 2009-07-09 Glenmark Pharmaceuticals Limited Topical composition comprising halobetasol and salicylic acid
WO2009062746A2 (en) * 2007-11-17 2009-05-22 Bayer Consumer Care Ag Topical drugs for use in antifungal therapy
US20090175810A1 (en) * 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US20090298805A1 (en) * 2008-06-03 2009-12-03 Polson George A Topical pyrithione compositions and methods for treatment of nail fungus
US20090324713A1 (en) * 2008-06-30 2009-12-31 Ulman John T Spray-on, non-woven fabric system and multilayer wound coverings
US20090324664A1 (en) * 2008-06-30 2009-12-31 Ulman John T Spray-on, non-woven fabric system and multilayer topical covering
US20100021530A1 (en) * 2008-07-25 2010-01-28 Innovation Biomedical Devices, Inc. Enhanced trans-keratin drug delivery
WO2010014199A2 (en) * 2008-07-29 2010-02-04 The Board Of Regents Of The University Of Texas System Uses of morelloflavone
JP2012516320A (en) * 2009-01-30 2012-07-19 イッスム リサーチ デベロプメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム リミテッド Composition for treating nails and skin
WO2010086732A1 (en) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Stable compositions for nail and skin treatment
US20100275942A1 (en) * 2009-05-01 2010-11-04 Barile Maria A Cosmetic nail covering
US20100292333A1 (en) * 2009-05-15 2010-11-18 bioCEPTA Corporation Compositions suitable for the topical treatment of fungal infections of the skin and nails
EP2434892B1 (en) * 2009-05-29 2015-08-19 Palau Pharma, S.A. Azole antifungal compositions
CN102574791A (en) 2009-08-05 2012-07-11 无限药品股份有限公司 Enzymatic transamination of cyclopamine analogs
AU2010283031A1 (en) * 2009-08-13 2012-01-19 Moberg Derma Ab Compositions and methods for treating fungal infection of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
WO2012037217A1 (en) 2010-09-14 2012-03-22 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
US20120082742A1 (en) * 2010-09-30 2012-04-05 Elorac, Ltd Method and compositions for treating cutaneous verrucae
CA2719512A1 (en) 2010-11-01 2012-05-01 Stiefel Research Australia Pty Ltd Polymeric topical compositions
AU2010238566B2 (en) * 2010-11-01 2012-09-20 Stiefel Research Australia Pty Ltd Polymeric topical compositions
FR2976806B1 (en) * 2011-06-22 2013-06-28 Urgo Lab FILMOGENIC TOPICAL COMPOSITION AND USE THEREOF FOR THE TREATMENT OF MYCOSES
FR2976808B1 (en) * 2011-06-22 2013-06-28 Urgo Lab FILMOGENE COMPOSITION AND USE THEREOF FOR THE TREATMENT OF HERPES
KR101281470B1 (en) * 2012-12-31 2013-07-03 전상문 Compositions for skin external comprising castor oil extracted hexane, undecylenic acid, propyl alcohol, propylene glycol and water for prevention or treatment of tinea pedis
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
JP6516759B2 (en) 2013-10-03 2019-05-22 ダウ ファーマシューティカル サイエンシーズ，インコーポレイティド Stabilized efinaconazole composition
KR102612453B1 (en) 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 Anti-infective methods, compositions, and devices
EP3091985B1 (en) 2014-01-10 2024-05-08 Manistee Therapeutics, Inc. Prostanglandins for topical use in the treatment of migraines.
US20160158393A1 (en) * 2014-02-21 2016-06-09 Avadim Technologies, Inc. Method for Improving Health Outcomes
CN106029156A (en) 2014-02-21 2016-10-12 阿瓦蒂姆技术股份有限公司 Methods of Maintaining Urethral Catheters
WO2015134500A1 (en) 2014-03-03 2015-09-11 Cook Medical Technologies Llc Mechanical dilator
JP2015212249A (en) 2014-05-05 2015-11-26 アナコール ファーマシューティカルズ，インコーポレイテッド Compound and nail polish
DK3209319T3 (en) 2014-10-21 2021-10-04 Hexima Ltd A PROCEDURE FOR TREATING FUNGI INFECTIONS
BR112017010557A2 (en) 2014-11-19 2017-12-26 Avadim Tech Inc method for acne prevention and treatment
CN107613987A (en) * 2015-03-31 2018-01-19 雷迪博士实验室有限公司 The topical spray composition of momestasone furoate
US10369147B2 (en) 2015-06-04 2019-08-06 PellePharm, Inc. Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
US20170231968A1 (en) * 2016-02-11 2017-08-17 PellePharm, Inc. Method for relief of and treatment of pruritus
JP2019509353A (en) * 2016-03-24 2019-04-04 バイオクレンズ・ピーエイチ・リミテッド・ライアビリティ・カンパニーＢｉｏｃｌｅｎｚ Ｐｈ Ｌｌｃ Treatment of skin conditions and diseases associated with microbial biofilms
CN107115329A (en) * 2017-04-28 2017-09-01 中国人民解放军第二军医大学第二附属医院 A kind of compound Butenafine preparation and its application
US12115139B2 (en) 2018-08-15 2024-10-15 Todd Alan Weinfield Treatment methods and processes for an infected nail
EP3982909A4 (en) 2019-06-12 2023-11-29 Avadim Health, Inc. COMPOSITIONS AND METHODS FOR THE ANTISEPTIC TREATMENT OF BIOFILM ON MAMMAL TISSUE
KR102774439B1 (en) 2022-11-11 2025-03-05 안재영 Cosmetic composition for nails and method for managing nails using the same

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR534810A (en) 1921-04-19 1922-04-03 Suspension device with counterweight and internal pulleys for electric lamp
DE1000567B (en) 1953-12-07 1957-01-10 Hans Fasching Erben K G Process for maintaining the fungicidal effect of antifungal substances when they are added to nail keratin-softening compounds (thioglycolates)
US4070317A (en) * 1968-05-29 1978-01-24 Deutsche Texaco Aktiengesellschaft Process for the production of film forming synthetic resins for hair fixatives
CH648481A5 (en) * 1981-06-26 1985-03-29 Joos Bernhard NAIL PROTECTION DEVICE FOR FASTENING AND / OR HARDENING LIVING FINGER AND / OR TOE NAILS.
DE3544983A1 (en) 1985-12-19 1987-06-25 Hoechst Ag ANTIMYCOTIC EFFECTIVE NAIL POLISH
HU200914B (en) 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
DE3720147A1 (en) 1987-06-16 1988-12-29 Hoechst Ag ANTIMYCOTICALLY EFFECTIVE NAIL POLISH AND METHOD FOR THE PRODUCTION THEREOF
US4956467A (en) 1988-04-01 1990-09-11 American Cyanamid Company Nucleophilic tertiary organophosphines
JP2797401B2 (en) * 1989-04-19 1998-09-17 日産化学工業株式会社 Antifungal composition for nails
US5476852A (en) * 1989-05-03 1995-12-19 Janssen Pharmaceutica N.V. Method of topically treating acne vulgaris, hyperkeratotic dermatoses, and photo-aging of the skin
IL97012A0 (en) 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
IL94806A0 (en) 1990-06-20 1991-04-15 Ernest Bar On Pharmaceutical preparation containing thiol derivatives together with other active compounds
IT1249047B (en) 1991-02-21 1995-02-11 Zambon Spa PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT
FR2673537B1 (en) * 1991-03-08 1993-06-11 Oreal USE OF HYDROPHILIC PENETRATION AGENTS IN DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF ONYCHOMYCOSES, AND CORRESPONDING COMPOSITIONS.
EP0508324B1 (en) * 1991-04-10 1999-03-17 Ruey J. Dr. Yu Use of cosmetic compositions comprising 2-hydrocarboxylic acids and related compounds for alleviating signs of nail changes
FR2687913A1 (en) * 1992-02-28 1993-09-03 Oreal COMPOSITION FOR TOPICAL TREATMENT CONTAINING LIPID VESICLES ENCAPSULATING AT LEAST MINERAL WATER.
FR2689008A1 (en) 1992-03-31 1993-10-01 Louis Benelli Compsns. for preventing hair loss and promoting regrowth - contain vasodilator e.g. minoxidil, keratolytic agent, and coal tar
DE4212105A1 (en) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nail polish for the treatment of onychomycoses
JPH06211651A (en) * 1993-01-12 1994-08-02 Hisamitsu Pharmaceut Co Inc Composition for treating nail trichophytosis
AU685082B2 (en) 1993-01-29 1998-01-15 Msd Consumer Care, Inc. Stable sulfide compositions, uses, and process for preparation thereof
IL105600A (en) 1993-05-04 1999-12-31 Allon Blank Pharmaceutical and cosmetic compositions with increased rate of transdermal penetration and antioxidation protection against degradation containing derivatives of thioglycolic and mercaptopropionic acids some such novel compounds and their use
US5461068A (en) * 1993-09-29 1995-10-24 Corwood Laboratories, Inc. Imidazole derivative tincture and method of manufacture
PH31594A (en) * 1993-09-30 1998-11-03 Janssen Pharmaceutica Nv Oral formulations on an antifungal.
FR2714597B1 (en) * 1993-12-30 1996-02-09 Oreal Moisturizing composition for the simultaneous treatment of the superficial and deep layers of the skin, its use.
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
DE19604190A1 (en) 1996-02-06 1997-08-07 Hoechst Ag Nail growth promoting preparations
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations

Also Published As

Publication number Publication date
HK1034189A1 (en) 2001-10-19
EP1067897A1 (en) 2001-01-17
AU3211999A (en) 1999-10-18
KR20010042324A (en) 2001-05-25
JP2002509867A (en) 2002-04-02
TWI225407B (en) 2004-12-21
CA2326774A1 (en) 1999-10-07
CN1295456A (en) 2001-05-16
WO1999049835A1 (en) 1999-10-07
CN1198563C (en) 2005-04-27
US6231875B1 (en) 2001-05-15
AR015257A1 (en) 2001-04-18

Similar Documents

Publication Publication Date Title
BR9909324A (en) Acidic composition for topical treatment of skin and nail conditions
BR9807577A (en) Method to prevent and delay the onset of Alzheimer&#39;s disease and its composition
FR2663850B1 (en) PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING A RETINOUIDE AND A STEROL IN COMBINATION.
BR0204596A (en) Topical composition, and methods for improving the aesthetic appearance of the skin, for enhancing the therapeutic efficacy of a topical composition for the skin, nail, lips and / or hair, and for enhancing the production of a predetermined plant cell constituent.
CY1108633T1 (en) COSMETIC COMPOSITION OF SUCRALFATE BASED AND COPPER AND ZONES SULFURS
ATE220536T1 (en) COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING SALICYLIC ACID OR DERIVATIVES THEREOF AND USE THEREOF
FI973468L (en) Method for manufacturing preparations for use in teeth whitening or in the treatment of skin and mucous membrane diseases
DE69600239D1 (en) Use of a bradykinin antagonist in a cosmetic, pharmaceutical or dermatological composition and the composition obtained
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
DE69932939D1 (en) FULVIC ACID AND ITS USE FOR THE TREATMENT OF VARIOUS DISEASE STATES
PT1173201E (en) METHOD FOR THE TREATMENT OF FIBROSIS USING AN ALTAGONIST OF THE ALPHA 4 SUBSTANCE OF INTEGRINA
ATE160561T1 (en) L-CARNITINE SALT, COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THIS FOR THE TREATMENT OF DERMATOSES
AU2002366433A1 (en) Methods and compositions for treating metabolic bone diseases relating to human endokine alpha
ES2162051T3 (en) DERMATOLOGICAL PREPARATION TO TREAT ACTINIC KERATOSIS.
ATE77230T1 (en) MELATONIN-CONTAINING AGENTS AND THEIR USES.
BR9903750A (en) Use of at least one rosacea extract of the genus sanguisorba and cosmetic process of pigmentation of the skin and / or hair and / or hair
BRPI0412424A (en) compound, pharmaceutical composition, method for treating dermatological or cancerous diseases in a mammal, composition, and method for treating skin or cancerous diseases
AU4626389A (en) Use of minoxidil for wound healing
PL369453A1 (en) Methods for improving the aesthetic appearance of skin
ATE240725T1 (en) AGENTS FOR THE TREATMENT OF LIGHT-DAMAGED SKIN WHICH CONTAIN A RAR-ALPHA ANTAGONIST AND A MULTI-SELECTIVE RETINOID
AR004326A1 (en) USE OF AT LEAST ONE TNF-ALPHA ANTAGONIST, COSMETIC, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITION CONTAINING SUCH ANTAGONIST AND COSMETIC DETREATMENT PROCEDURE USING SUCH ANTAGONIST.
AU2859295A (en) New composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effect in human beings and animals
BR9814945A (en) Use of phanquinone for the treatment of alzheimer&#39;s disease, pharmaceutical composition and kit
BR0204618A (en) Methods for treating fine lines and / or wrinkles, and for improving the aesthetic appearance of the skin or lips, and topical composition
DK0700897T3 (en) L-carnitine salt and cosmetic and pharmaceutical preparations containing the same for the treatment of skin diseases

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1990 DE 25/02/2009.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 3/02 (2006.01), A61K 8/20 (2006.0